Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Table 1 Frequency of selected autoantibodies in the CSRG cohort

From: Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

  n % Numbers not tested
CENP-B 285 36% 162
Centromere by IIF 334 35% 2
CENP-A 275 34% 162
Ro52/TRIM21 194 20% 0
RNA polymerase III 144 19% 188
Topoisomerase I 150 16% 0
PM/Scl 53 7% 188
Ro60 53 6% 0
U1 RNP 59 6% 0
Chromatin 44 5% 0
Sm 39 4% 0
SS-B/La 26 3% 0
Jo-I 6 1% 0
Ribosomal P 14 1% 0
  1. N = 963. CENP, centromere protein; IIF, indirect immunofluorescence; PM/Scl, polymyositis/scleroderma (exosome) autoantigen; RNP, ribonucleoprotein; Sm, Smith autoantigen; SS-B, Sjögren syndrome antigen B or La.